{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=PD+0332334", "query": { "intervention": "PD 0332334" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-05T15:59:11.569Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00537615", "title": "An Open-label Study to Investigate the Absorption, Metabolism and Excretion of Radiolabeled PD 0332334 in Six Healthy Male Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Generalized Anxiety Disorder" ], "interventions": [ { "name": "PD 0332334", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "MALE", "summary": "18 Years to 55 Years · Male only" }, "enrollment_count": 6, "start_date": "2007-09", "completion_date": "2007-10", "has_results": false, "last_update_posted_date": "2010-02-17", "last_synced_at": "2026-09-05T15:59:11.569Z", "location_count": 1, "location_summary": "New Haven, Connecticut", "locations": [ { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT00537615" }, { "nct_id": "NCT00542685", "title": "A 10-Week Study Evaluating the Efficacy And Safety of PD 0332334 for the Treatment of Generalized Anxiety Disorder", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Generalized Anxiety Disorder" ], "interventions": [ { "name": "PD 0332334", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 551, "start_date": "2007-10", "completion_date": "2008-12", "has_results": false, "last_update_posted_date": "2012-11-16", "last_synced_at": "2026-09-05T15:59:11.569Z", "location_count": 43, "location_summary": "Beverly Hills, California • Encino, California • National City, California + 37 more", "locations": [ { "city": "Beverly Hills", "state": "California" }, { "city": "Encino", "state": "California" }, { "city": "National City", "state": "California" }, { "city": "Newport Beach", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00542685" }, { "nct_id": "NCT00658372", "title": "A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder (2)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Generalized Anxiety Disorder" ], "interventions": [ { "name": "PD 0332334", "type": "DRUG" }, { "name": "Paroxetine", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 360, "start_date": "2008-05", "completion_date": "2009-03", "has_results": false, "last_update_posted_date": "2012-11-16", "last_synced_at": "2026-09-05T15:59:11.569Z", "location_count": 29, "location_summary": "Arcadia, California • Costa Mesa, California • Escondido, California + 25 more", "locations": [ { "city": "Arcadia", "state": "California" }, { "city": "Costa Mesa", "state": "California" }, { "city": "Escondido", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00658372" }, { "nct_id": "NCT00836069", "title": "Fixed Dose Study of PD 0332334 and Paroxetine for the Treatment of Generalized Anxiety Disorder", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Anxiety Disorders" ], "interventions": [ { "name": "No drug name provided by Sponsor; drug referenced as PD 0332334", "type": "DRUG" }, { "name": "Paroxetine", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cedars-Sinai Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 5, "start_date": "2008-10", "completion_date": "2010-04", "has_results": false, "last_update_posted_date": "2019-08-21", "last_synced_at": "2026-09-05T15:59:11.569Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00836069" }, { "nct_id": "NCT00658008", "title": "A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder (1)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Generalized Anxiety Disorder" ], "interventions": [ { "name": "PD 0332334", "type": "DRUG" }, { "name": "Paroxetine", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 501, "start_date": "2008-04", "completion_date": "2009-03", "has_results": false, "last_update_posted_date": "2012-11-16", "last_synced_at": "2026-09-05T15:59:11.569Z", "location_count": 45, "location_summary": "Litchfield Park, Arizona • Costa Mesa, California • Pasadena, California + 37 more", "locations": [ { "city": "Litchfield Park", "state": "Arizona" }, { "city": "Costa Mesa", "state": "California" }, { "city": "Pasadena", "state": "California" }, { "city": "Redlands", "state": "California" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00658008" }, { "nct_id": "NCT00738738", "title": "6-Month Open-Label Safety Study Of PD 0332334 In Elderly Patients With Generalized Anxiety Disorder (GAD)", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Generalized Anxiety Disorder" ], "interventions": [ { "name": "PD-0332334", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "65 Years", "maximum_age": null, "sex": "ALL", "summary": "65 Years and older" }, "enrollment_count": 0, "start_date": "2009-01", "completion_date": "2009-02", "has_results": false, "last_update_posted_date": "2012-12-03", "last_synced_at": "2026-09-05T15:59:11.569Z", "location_count": 2, "location_summary": "Orlando, Florida • Prairie Village, Kansas", "locations": [ { "city": "Orlando", "state": "Florida" }, { "city": "Prairie Village", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00738738" }, { "nct_id": "NCT00735267", "title": "A 52-Week Open-Label Safety Study of PD 0332334 in Subjects With Generalized Anxiety Disorder (GAD)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Generalized Anxiety Disorder" ], "interventions": [ { "name": "PD 0332334", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 468, "start_date": "2008-10", "completion_date": "2009-04", "has_results": false, "last_update_posted_date": "2012-11-16", "last_synced_at": "2026-09-05T15:59:11.569Z", "location_count": 93, "location_summary": "Birmingham, Alabama • Litchfield Park, Arizona • Arcadia, California + 79 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Litchfield Park", "state": "Arizona" }, { "city": "Arcadia", "state": "California" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Costa Mesa", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00735267" }, { "nct_id": "NCT00800280", "title": "Evaluating The Effects Of Cimetidine On The Elimination Of PD 0332334 From The Body", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Generalized Anxiety Disorder" ], "interventions": [ { "name": "PD 0332334", "type": "DRUG" }, { "name": "cimetidine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 12, "start_date": "2009-01", "completion_date": "2009-02", "has_results": false, "last_update_posted_date": "2010-02-17", "last_synced_at": "2026-09-05T15:59:11.569Z", "location_count": 1, "location_summary": "New Haven, Connecticut", "locations": [ { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT00800280" }, { "nct_id": "NCT00721422", "title": "A Single Dose Study Investigating the Elimination as Well as the Tolerability of PD 0332334 in Healthy Subjects as Compared to Patients With Impaired Kidney Function.", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Renal Insufficiency", "Pharmacokinetics" ], "interventions": [ { "name": "PD 0332334", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 16, "start_date": "2008-08", "completion_date": "2009-02", "has_results": false, "last_update_posted_date": "2010-02-17", "last_synced_at": "2026-09-05T15:59:11.569Z", "location_count": 2, "location_summary": "Cypress, California • Miami, Florida", "locations": [ { "city": "Cypress", "state": "California" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00721422" }, { "nct_id": "NCT00658762", "title": "A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 for the Treatment of Generalized Anxiety Disorder (3)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Generalized Anxiety Disorder" ], "interventions": [ { "name": "PD 0332334", "type": "DRUG" }, { "name": "paroxetine", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 286, "start_date": "2008-05", "completion_date": "2009-04", "has_results": false, "last_update_posted_date": "2012-11-16", "last_synced_at": "2026-09-05T15:59:11.569Z", "location_count": 27, "location_summary": "Birmingham, Alabama • Glendale, California • Orange, California + 22 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Glendale", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Temecula", "state": "California" }, { "city": "Upland", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00658762" } ] }